Clark Julie 4
4 · Adverum Biotechnologies, Inc. · Filed Oct 4, 2021
Insider Transaction Report
Form 4
Clark Julie
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-09-30$2.17/sh−4,766$10,342→ 164,723 total
Footnotes (1)
- [F1]The shares were sold pursuant to an irrevocable election previously made by the Reporting Person to sell shares of common stock necessary to cover the federal, state and local tax withholding obligations, as well as related brokerage commission fees.